Key result
Right ventricular circumferential strain assessed by CMR-FT independently predicted major adverse events in patients with Brugada syndrome.
Why the study?
The study evaluated the prognostic significance of CMR feature tracking in Brugada syndrome to detect subclinical alterations and predict major adverse events.
Does cardiac magnetic resonance myocardial feature tracking predict major adverse events in patients with Brugada syndrome?
Cohort (n=131)
Does cardiac magnetic resonance myocardial feature tracking predict major adverse events in patients with Brugada syndrome?
Cardiac magnetic resonance feature tracking, specifically RV circumferential strain and RVOT size, provides independent prognostic information for predicting major adverse events in patients with Brugada syndrome.
Answers are grounded in this paper and cite their sources.
RV strain by CMR-FT may aid Brugada syndrome risk stratification; hypothesis-generating pending prospective validation.
OBJECTIVE: This study evaluated the prognostic significance of cardiac magnetic resonance myocardial feature tracking (CMR-FT) in patients with Brugada syndrome (BrS) to detect subclinical alterations and predict major adverse events (MAE). METHODS: CMR was performed in 106 patients with BrS and 25 healthy controls. Biventricular global strain analysis was assessed using CMR-FT. Patients were followed over a median of 11.6 [8.8 ± 13.8] years. RESULTS: The study cohort was subdivided according to the presence of a spontaneous type 1 ECG (sECG) into sBrS (BrS with sECG, n = 34 (32.1%)) and diBrS (BrS with drug-induced type 1 ECG, n = 72 (67.9%)). CMR-FT revealed morphological differences between sBrS and diBrS patients with regard to right ventricular (RV) strain (circumferential (%) (sBrS -7.9 ± 2.9 vs diBrS - 9.5 ± 3.1, p = 0.02) and radial (%) (sBrS 12.0 ± 4.3 vs diBrS 15.4 ± 5.4, p = 0.004)). During follow-up, MAE occurred in 11 patients (10.4%). Multivariable analysis was performed to identify independent predictors for the occurrence of events during follow-up. The strongest predictive value was found for RV circumferential strain (OR 3.2 (95% CI 1.4 - 6.9), p = 0.02) and RVOT/BSA (OR 3.1 (95% CI 1.0 - 7.0), p = 0.03). CONCLUSIONS: Myocardial strain analysis detected early subclinical alterations, prior to apparent changes in myocardial function, in patients with BrS. While usual functional parameters were within the normal range, CMR-FT revealed pathological results in patients with an sECG. Moreover, RV circumferential strain and RVOT size provided additional prognostic information on the occurrence of MAE during follow-up, which reflects electrical vulnerability.
No takes yet. Share an insight, caveat, or question.
Hohneck et al. (2021) conducted a cohort in Brugada syndrome (n=131). Right ventricular circumferential strain was evaluated on Major adverse events (MAE) (OR 3.2, 95% CI 1.4 - 6.9, p=0.02). Right ventricular circumferential strain assessed by CMR-FT independently predicted major adverse events in patients with Brugada syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: